Gene therapy drugs could cost healthcare $45B in the next 5 years, report says

(By Maia Anderson for Becker’s Hospital Review)

Gene therapy drugs have the potential to relieve or cure genetic disorders that have previously gone untreated, but the price of such treatments could cost the healthcare industry as much as $45 billion within the next five years, according to a report published by CVS Health.  Continue reading article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.